Form D · Private Equity Fund
HIPEP X Fund L.P.
Boston, MA · CIK 0001958519
Offering snapshot reported May 24, 2024 · SEC filing
- Reported sold
- $483M Indefinite offering
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 8, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 5
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 24, 2024 | Amendment | $482,500,000 | No comparison | 5 | SEC filing |
| May 26, 2023 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-482778
Source: Form D, filed May 24, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
HIPEP X FUND L.P.
Investment adviser: HARBOURVEST PARTNERS, LLC
- Gross asset value
- $953M
- Beneficial owners
- 10
- ADV minimum commitment
- $1.5M
Reported in Form ADV on Jul 16, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- No
- External marketing
- Yes
PRICEWATERHOUSECOOPERS LLP
PCAOB 238
JPMORGAN CHASE BANK, N.A.
LEI 7H6GLXDRUGQFU57RNE97
Filing source
Form ADV 2119531 · Jul 16, 2026 · Schedule D 7.B.(1), fund 805-1246235825
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David A. Atterbury | Executive |
| Paula Drake | Executive |
| Corentin Du Roy De Blicquy | Executive |
| Carolina Espinal | Executive |
| Timothy E. Flower | Executive |
| Brett A. Gordon | Executive |
| Ryan Gunther | Executive |
| James Kase | Executive |
| Jeffrey R. Keay | Executive |
| Ian C. Lane | Executive |
| Peter B. Lipson | Executive |
| Hemal Mirani | Executive |
| John G. Morris | Executive |
| Michael Pugatch | Executive |
| Alex A. Rogers | Executive |
| Rajesh Senapati | Executive |
| Gregory V. Stento | Executive |
| Hemal Thakore | Executive |
| John M. Toomey, Jr. | Executive |
| Mary Traer | Executive |
| Scott C. Voss | Executive |
| Peter G. Wilson | Executive |
| Kelvin Yap | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:Boston, MA, 02111